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Summary: Diamine oxidase in vaginal effluent is used äs a parameter for ascertaining the state of fetal
membranes. A new method using tritiated putrescine äs a Substrate is described for the determination of
diamine oxidase in amniotic fluid and vaginal effluents. A number of tests are used for the diagnosis of
premature rupture of fetal membranes. The described procedure for diamine oxidase activity determination
can be used in general hospitals and has advantages over other parameters such äs pH, glucose or fructose
concentration, and the amniotic fluid crystallization test.
Introduction
Premature rupture of fetal membranes, defined äs
rupture of the membranes before onset of labor, oc-
curs in 3 — 14% of all births (1 — 3). A relationship
has been reported between premature rupture of fetal
membranes and maternal septic morbidity and mor-
tality (4—6). Premature rupture is also associated with
increased incidence of amnionitis, fetal immaturity
and fetal and infant morbidity and mortality (7 — 11).
Management of premature rupture of fetal mem-
branes is still contrpversial and diagnosis is sometimes
difficult. Many procedures have been described and
are still used for the diagnosis of premature rupture
pf fetal membranes, such äs measurement of pH,
glucose and fruetose in the vaginal effluent, and the
amniotic fluid crystallization test (fern test) (11—16).
Unförtunately, none of these appears to be fülly sät-
isfactory in doubtful cases. It has been reported that
amniotic fluid contains a relatively large amount of
the enzyme diamine oxidäse (EC 1.4.3.6), which is
absent in vaginal secretions, and might be used äs a
marker for premature rupture of fetal membranes (3,
17 — 20). Diamine oxidase catalyses the oxidation of
*) formerly: de Wever Hospital, Heerlen.
histamine and the aliphatic diamines 1,4-diaminobu-
tane (putrescine) and 1,5-diaminopentane (cadaver-
ine). In human serum or plasma the diamiiie oxidase
activity is normally low,but it is markedly increased
in pregnäncy (21). The diamine oxidase activity in
amniotic fluid is variable, and at term the levels are
lower than in maternal plasma (22).
The physiological role of the enzyme in pregnancy
remains to be determined. Diamine oxidase is located
in maternal decidual cells. It has been suggested that
its localisation in the placenta allows the enzyme to
act äs a barrier to prevent the entry of histamine and
polyamines into the maternal circulation (28).
The increase of diamine oxidase activity during preg-
nancy is thought to result from secretion or more
probably from lysis of decidual cells with entry of the
enzyme into the circulation (23). The increase has also
been described in neoplasia, disorders of the gastroin-
testinal tract (24), allergic states (25) and cystic fibro-
sis (26).
In diagnosing early rupture of fetal membranes, it is
often difficult to identify the nature of the fluid in the
upper vagina. Contaminants may be blood, urine,
cervical mucus, which may be secreted abundantly at
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term, fluor or semen. It has been suggested that in
the absence of vaginal bleeding, diamine oxidase ac-
tivity in the vaginal fluid can be used for the diagnosis
of ruptured fetal membranes (3,17-20). The diamine
oxidase activity appears to be present in the vaginal
discharge up to two hours after the appearence of
amniotic fluid in the vagina (l 8). The overall accuracy
of diamine oxidase activity determinations in vaginal
fluid for diagnosing the rupture of fetal membranes,
in the absence of vaginal bleeding, is reported to be
96-l00% (l7, 18).
As vaginal fluid samples are often small in volume, a
sensitive analysis is required, especially for equivocal
cases of suspected fetal membrane rupture. The design
of a suitable assay for diamine oxidase, which is
reliable and can be used in emergency situations, has
proved problematic. The spectrophotometric assay is
simple to perform but requires too much sample (27).
An HPLC method has been described, but is consid-
ered to be elaborate and time consuming (28).
Diamine oxidase can be elegantly measured by oxi-
dative deamination of [l-14C]l,4-diaminobutane or
[l-14C]l,5-diaminopentane. The products from these
two Substrates undergo non-enzymatic cyclisation to
form [14C]pyrroline or [14C]piperidine, respectively,
and these can be measured after extraction in the
organic phase (29 — 31).
In our study we used [3H]l,4-diaminobutane äs sub-
strate. We investigated the relation of diamine oxidase
activity in maternal serüm and amniotic fluid in re-
lation to gestational age. Sensitivity and specificity
for diagnosis of the state of fetal membranes was
determined from frozen vaginal fluid samples of pa-
tients and of a reference population.
Patients
Patients from the obstetric departments of the Academic Hos-
pital Maastricht (Maastricht), De Wever-Hospital (Heerlen),
and the obstetric clinic St. Elisabeth Clinic (Heerlen), were
included in this study. The collection of material from patients
suspected for premature rupture of fetal membranes was per-
formed over a period of 18 months at these centres. Suspicion
of premature rupture of fetal membranes was based on cliiiical
data. The diagnosis of ruptured membranes was established if
the patient had a marked continuous fluid loss and no mem-
branes were feit at the first vaginal examination. The vaginal
fluid sample from those patients was considered to be amniotic
fluid. In contrast, in patients who delivered more than four
weeks after the initial complaints and had an uneventfül preg-
nancy without any vaginal fluid loss, or intact membranes were
feit at the time of the delivery, the membranes were considered
äs intact and the vaginal fluid was considered not to be amniotic
fluid.
Material was collected from 120 patients (8.2% of the recorded
number of 1469 deliveries). Sufflcient Information was present
from 100 patients for retrospective diagnosis. These patients
were included in the study, and they revealed a premature
rupture of fetal membranes prevalence of 39%.
For determination of diagnostic capacity and reference intervals
for diamine oxidase activity, flüids of different and known
origin were collected. These included amniotic flujd äs well äs
fluids that might be found äs vaginal effluent during pregnancy:
urine, cervical mucus, fluor vaginalis or blood.
Amniotic fluid was collected from 14£ patients with amenor-
rhoea of 16 to 42 weeks by amniotic puncture or by deliberately
performing rupture of the fetal membranes. In cases with pre-
mature rupture of fetal membranes, midstream urine or catheter
urine was obtained. Cervical mucus and fluor vaginalis were
obtained only when the fetal membranes were intact. All sam-
ples were stored at —20 °C until examination. Gestational age
was recorded.
Materials and Methods
1,4-Diaminobutane dihydrochloride (putrescine dihydrochlor-
ide, Lot No. 15F-0555) and diamine oxidase (EC 1.4.3.6, 0.06
U/mg at pH 7.2, 37 °C, P-7876, Lot No. 56 F-8130) were
obtained from Sigma Chemicals. [3H]l,4-diaminobutane ([2,3-
3H(N)] putrescine dihydrochloride), 37 GBq/1, specific activity
910 GBq/mmol, was obtained from New England Nuclear (Lot
No. 2299-72).
All other reagents were purchased from Merck, Darmstadt,
Germany. Phosphate buffer (0.2 mol/1) was prepared by adding
a solution of 0.2 mol/1 KH2PO4 to a solution of 0.2 mol/1
Na2HPO4 until pH 7.40 was reached.
Alkaline buffer: to a saturated solution of NaHCO3 at room
temperature, after filtration, NaOH (2.0 mol/1) was added until
pH 12.2 was reached.
Perchloric acid solution (1.7 mol/1) was prepared by the addition
of 14.0 ml 700 g/kg HC1O4 in H2O to give a final volurne of
100 ml.
Substrate solution [3H]l,4-diaminobutane/l,4-diaminobutane:
98.8 kBq/l//4.5 mmol/1 was prepared in phosphate buffer.
Extraction/scintillation solution was prepared by dissolving
5.60 g PPO in 11 toluene. , .....
Fresh Solutions were prepared every two weeks. Protein was
determined by the method of Iwala et al. (32).
Radioactivity was measured with a Kontron MR 300 Liquid
Scintillation Counter, with automatic background substractipn
of instrumental background and quench control. Counting time
was 10 minutes per sample.
Procedure
All determinations were performed on coded samples in dupli-
cate. After thawing, the samples were eentrifuged for 10 min
at 3000 g. Determination of diaraine oxidase activity, in samples
other than serum or amniotic fluid, was determined after saune
extraction, to avoid problems of viscosity. The samples (l vol.)
were twice mixed with isotonic saline (2 vol.) and eentrifuged.
The aqueous supernatants were mixed and used for the diamine
oxidase assay. Protein was also determined in the extraet. This
procedure was also applied to samples from the patient group
suspected of premature rupture of fetal membranes.
Diamine oxidase determination e:
To 500 phosphate buffer in a disposable tube, 200 serum,
amniotic fluid or saline extraet was added and mixed. For the
sample blank, 200 perchloric acid was used. A pre-mcubation
was performed in closed tube for 15 min at 37 °C The assay
was started by the addition of 50 li[(?H]l,4-diaminobutane/l,4-
diaminobutane solution, the tube closed and immediately
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mixed. After exactly 60 min at 37 °C the reaction was stopped
by the addition of 200 μΐ perchloric acid and irarnediately mixed.
Serum, amniotic fluid or saline extract (200 μΐ) was added to
the sample blank.
The extraction was performed by the addition of l ml alkaline
buffer and 6 ml PPO solution. After vigorously mixing for l
minute, the tubes were centrifuged for 20 min at 3000 g. The
aqueous phase was separated by freezing in an ethanol-solid
CO2 mixture at — 78 °C. The organic phase was decanted into
counting vials, and the radioactivity was measured.
Within each run a blank, purified diamine oxidase solution
(0.5, 1.0, 1.5, 2.0 U/l) and three quality assessment samples
were determined. The quality assessment samples were aliquots
of amniotic fluid stored at — 20 °C.
When the coefficient of Variation for duplicate determinations
was greater than 10%, the analysis was repeated. Enzymatic
activity of the samples was calculated from Interpolation of the
linear calibration curve. Samples with diamine oxidase activity
above 2.0 U/l were diluted in saline (l : 5) and reanalysed.
0.04
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Fig. 2. Lineweaver- urk plot for diamine oxidase in amniotic
fluid. Km = 19μπκ>1/1.
Results
Optimal assay conditions for amniotic fluid
The pH Optimum for diamine oxidase determination
in amniotic fluid and for purified enzyme were deter-
mined. The optimal pH for amniotic fluid was pH
= 7.4. A sample size of 200 μΐ was chosen to obtain
adequate accuracy and precision.
A linear relation between incubation time and meas-
ured product was found (fig. 1) at a Substrate con-
centration 300 μηιοΐ/ΐ. The Km, determined in a ran-
dorn sample of amniotic fluid, was 19 μπιοΐ/ΐ (flg. 2).
The chosen substrate concentration was 300 μιηοΐ/l
(15 χ ATm), and at this substrate concentration no
enzyme inhibition was fo nd. G od linearity was
found for diamine oxidase activity in dilutions of
purified diamine oxidase in amniotic fluid.
1100-J
80-
Χ 60-
40-
20-
10 20 30 40
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Fig. 1. Diamine oxidase activity in amniotic fluid; incubation
time (minutes) versus formation of reaction prod ct
(arbitrary units). Substrate concentration 300 μηιοΐ/ΐ;
sample volume 200 μΐ; total volume 750 μΐ.
In the tested r nge (up to 2 U/l), good linearity for
diamine oxidase activity was also found with dilutions
of amniotic fluid and purified enzyme in saline.
Blanks and controls
Blank values were determined in each run together
with controls (purified enzyme preparation). Mean
courit rate v lue for blanks was 2083 counts/min; day
to day Variation was 18%. "Zero activity" was defined
at twice the blank count rate. This was clearly differ-
ent from the count rate of the lowest control (0.27
U/l), which had a mean value of 7516 counts/min;
day to day Variation was 14%.
Recovery and matrix effects
Recovery of purified diamine oxidase in amniotic fluid
was 98.2% + 10 (n = 10). Recovery of amnion dia-
mine oxidase in a serum pool was 99.1% ±10
(n = 8).
Recovery of amnion diamine oxidase in vaginal ef-
fluent after saline extraction was 104.1% ±9.8
(n = 11). In urine no diamine oxidase activity was
detectable. Prior to the experiment the urines were
adjusted to pH 7.4. Recovery of diamine oxidase
activity in urine after the addition of amniotic fluid
was always less than 100%. Figure 3 demonstrates
the inhibitory effect of urine on the enzyme activity.
Statistics
The correlation coefficient of the calibration curves
varied from 0.950 to 0.999 (mean 0.993, n = 17).
Eun J. Clin. Chem. Clrn. Biochem. / Vol. 29,1991 / No. 11
746 Bank et al.: Diamine oxidase in amniotic fluid
1.00< l
0.20 0.40 0.60 0.80
Urine in amniotic fluid, volume fraction
1.00
Fig. 3. Decrease of diamine oxidase activity in amniotic fluid
upon increasing addition of urine.
Intra- and inter-run coefficients of Variation were
determined with aliquots of the three quality assess-
ment samples (tab. 1).
Tab. l. Intra- and inter-run coefficients of Variation for diamine
oxidase activity determination in amniotic fluid.
Sample Intra-run (n = 20) Inter-run (n = 14)
1
2
3
Diamine
oxidase
(U/l)
1.18
1.06
0.27
CV
(%)
3.2
4.3
9.6
Diamine
f oxidase
(U/l)
1.17
1.04
0.27
CV(%)
11.0
13.2
26.4
Tab. 2. Diamine oxidase activity (mean ± SD) in amniotic
fluid in relation to gestational age (total number of
patients 145).
Amenorrhoea
(weeks)
16-19
20-23
24-27
28-31
32-35
36-42
Patients
(n)
12
8
14
12
25
74
Diamine oxidase
activity (U/l)
0.27 + 0.21
1.11 + 1.48
1.45 + 1.30
0.85 + 0.54
0.72 ± 0.76
0.67 ± 0.80
Reference population
Diamine oxidase activity in amniotic fluid was meas-
ured in the reference population (n = 145). The re-
sults in relation to gestational age are shown in table
2. Highest values were found at 24—27 weeks gesta-
tional age.
Diamine oxidase activity in serum was measured in
an extended reference population (n = 201). The re-
sults in relation to gestational age are shown in
table 3.
With the exception of one fluor sample (diamine
oxidase activity 1.0 U/g protein), saline extracts of
fluor vaginalis (n = 58) and cervical mucus (n = 15)
contained no detectable diamine oxidase activity. Pro-
tein was determined in amniotic fluid, vaginal fluid,
cervical mucus and serum, in order to quantitate the
effluent (tab. 4).
A number of patients' urine samples (n = 167) were
also analysed; only 15 samples contained protein and
all values were below 0.5 g/l. Moreover, a limited
number (n = 15) of husband's semen samples were
analysed, and found to contain 53.6 + 5.7 g/l protein.
Patients suspected of premature rupture of
fetal membranes
Diamine oxidase was determined in the vaginal fluid
(with saline extraction) and expressed äs U/g protein.
Tab. 3. Diamine oxidase activity (mean ± SD) in serum in
relation to gestational age (total number of patients
201).
Amenorrhoea
(weeks)
16-19
20-23
24-27
28-31
32-35
36-42
Patients
(n)
« , .19
20
26
32
85
Diamine oxidase
activity (U/l)
0.39 ± 0.24
0.64 + 0.28
0.70 ± 0.39
0.76 + 0.40
0.67 ± 0.36
0.90 + 1.07
Tab. 4. Protein concentrations (mean + SD) in amniotic fluid,
vaginal fluor, cervical mucus and serum during preg-
nancy.
Amenor-
rT"H~»<*SI
(weeks)
Protein concentration (g/l)
Amniotic
fluid
16-19
20-23
24-27
28-31
32-35
36-42
Number of
patients
7
9
7
5
4
2
.3
.1
.2
.3
.0
.8
±
±
+
±
-h
±
129
4.9
6.8
3.7
2.3
2.1
1.2
Vaginal Cervical
fluor
1.1
1.0
0.7
0.8
0.8
3.0
±
±
±
±
±
±
58
mucus*
0.9 0.6
1.0 -
0.4 -
0.6 -
0.9 0.1,
3.4 5.2 ± 2.4
15
Serum
63
65
62
.7
.5
.1
59,8
57
58
.6
.6
±
±
4-
±
±
±
6.7
6.6
5.2
5.7
6.2
7.0
126
* Cervical mucus was obtained anji analysed from 15 patients
in total, of whom 13 were in the last group.
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Tab. 5. Sensitivity and specificity ofdiamine oxidase activity in
vaginal fluid for diagnosis of premature rupture of fetal
membranes.
Diamine oxidase
cut-ofT value
(U/g protein)
0
0.05
0.1
0.2
0.3
0.4
Sensitivity
(%)
74.4
53.8
41.0
23.1
7.7
5.1
Specificity
(%)
83.6
90.2
96.7
96.7
98.4
98.4
Values from 0 to l .67 U diamine oxidase per g protein
were found. The correct diagnosis (yes/no ruptured
membranes) was detennined retrospectively. For di-
agnostic purposes Receiver Operating Characteristic
(ROC) curves were detennined (tab. 5, fig. 4). The
optimal cut-off value appears to be at zero activity
of diamine oxidase in the vaginal effluent: Sensitivity
74.4%, specificity 83.6%. If the elevated diamine ox-
idase values were due to blood in the vaginal fluid,
this was confirmed by elevated protein values in the
effluent.
100-1
40 60
100-Specificity [%]
80 100
Fig. 4. Receiver Operating Characteristic (ROC) of diamine
oxidase for diagnosis of premature rupture of fetal
membranes (numerical data are given in table 5).
Discussion
The cliagnosis premature rupture of fetal membranes
is sometimes difficult to establish. This is primarily
due to the lack of a measurable difference in the
composition of amniotic fluid and vaginal effluent.
In an attempt to overcome this problem, we deter-
mined diamine oxidase in vaginal effluent. 14C-la-
belled putrescine has been proposed äs a Substrate.
As this label was difficult to handle in our hospital
laboratory, in contrast to routine measurements using
tritium, we introduced [3H]putrescine äs a Substrate.
The intra-run reproducibility of the method was good,
but the measurement technique was hampered by an
inter-run coefficient of Variation, at very low enzyme
activity levels, of 26.4%. We determined the diamine
oxidase activity in the vaginal effluent of 100 patients
in order to evaluate its potential äs a method in the
diagnosis premature rupture of fetal membranes. In
all of these patients the state of the membranes was
confirmed retrospectively. Prevalence of premature
rupture of fetal membranes in this population was
39%. The results of this study indicate that the sen-
sitivity and specificity of the diamine oxidase activity
were 74% and 84%, respectively, at a cut-off value
of zero diamine oxidase activity. Both the Sensitivity
and specificity of the diamine oxidase activity deter-
mination are higher than the Sensitivity and specificity
(both below 70%) of pH determination and the fern
test (33), which are the most common tests for de-
tecting amniotic fluid. If diamine oxidase activity was
detected,it was then necessary to determine whether
this was due to amniotic fluid or blood. As the protein
concentrations in blood are much higher than in am-
niotic fluid (upper limit below 10 g/l; tab. 4) the pro-
tein content of the effluent plays an important role
in this differentiation.
On the basis of these results it is concluded that the
determination of diamine oxidase activity represents
a useful method for this purpose in general hospitals.
However, it should be emphasized that the accuracy
of 96% reported previously (17—18) could not be
confirmed.
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